Stocks and Investing Stocks and Investing
Tue, July 18, 2023
Mon, July 17, 2023

Raghuram Selvaraju Maintained (AXSM) at Strong Buy with Decreased Target to $190 on, Jul 17th, 2023


Published on 2024-10-28 04:52:03 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $200 to $190 on, Jul 17th, 2023.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 1 agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $90 on, Monday, June 12th, 2023


These are the ratings of the 3 analyists that currently disagree with Raghuram


  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $104 on, Thursday, June 22nd, 2023
  • Yatin Suneja of "Guggenheim" Reiterated at Strong Buy and Held Target at $110 on, Thursday, June 15th, 2023
  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $95 on, Wednesday, June 14th, 2023